Encyclopedia of Cancer
Encyclopedia of Cancer
Editor/Author
Schwab, Manfred
Publication Year: 2017
Publisher: Springer Science+Business Media
Single-User Purchase Price:
$2499.99

Unlimited-User Purchase Price:
Not Available
ISBN: 978-3-662-46875-3
Category: Health & Medicine - Medicine
Image Count:
1239
Book Status: Available
Table of Contents
This work comprehensively describes etiological factors in the development , Progression and metastasis of human cancers, both for hematological malignancies and for solid Tumors.
Table of Contents
- Preface to the Fourth Edition
- Preface to the Third Edition
- Preface to the Second Edition
- Preface to the First Edition
- Editors and Contributors
- A
- AAMP
- AAV
- ABC Drug-Transporters
- ABCC Transporters
- ABC-Transporters
- Abraxas
- Abscopal Effects
- ABVD
- Achneiform Rash
- Actinic Keratosis
- Activated Natural Killer Cells
- Activation-Induced Cytidine Deaminase
- Active Specific Immunization
- Activin
- Activin Receptors
- Acute Lymphoblastic Leukemia
- Acute Megakaryoblastic Leukemia
- Acute Myeloid Leukemia
- Acute Promyelocytic Leukemia
- ADAM Molecules
- ADAM17
- Adaptive Immunity
- Adaptor Proteins
- Adducts to DNA
- Adenocarcinoma
- Adenoma
- Adenopathy
- Adenosine and Tumor Microenvironment
- Adenovirus
- Adherens Junctions
- Adhesion
- Adiponectin
- Adipose Tumors
- Adjuvant Chemoendocrine Therapy
- Adjuvant Therapy
- ADMET Screen
- Adoptive Immunotherapy
- Adoptive T-Cell Transfer
- Adrenocortical Cancer
- Adrenomedullin
- Adriamycin
- Adult Stem Cells
- Adult T-Cell Leukemia
- Aflatoxins
- Aflibercept
- Aggressive Fibromatosis in Children
- Aging
- Aging-Associated Inflammation
- AIDS-Associated Malignancies
- Akt Signal Transduction Pathway
- Alcohol Consumption
- Alcoholic Beverages Cancer Epidemiology
- Alcoholic Pancreatitis
- Aldehyde Dehydrogenases
- ALK Protein
- Alkylating Agents
- Allele Imbalance
- Allergy
- Allogeneic Cell Therapy
- Alpha-Fetoprotein
- Alpha-Fetoprotein Diagnostics
- Alu Elements
- AME Transcription Factor
- Amine Oxidases
- Amphiregulin
- Amplification
- Amplified in Breast Cancer 1
- Amrubicin
- Anaplastic Large Cell Lymphoma
- Anaplastic Lymphoma Kinase
- Anchorage-Independent
- Androgen Ablation Therapy
- Androgen Receptor
- Androgen-Independent Prostate Cancer (AIPC)
- Aneuploidy
- Angiogenesis
- Angiogenin
- Angiopoietins
- Angiotensin II Signaling
- Anoikis
- Anoxia
- Ansamycin Class of Natural Product Hsp90 Inhibitors
- Anthracyclines
- Antiangiogenesis
- Antibody-Dependent Cellular Cytotoxicity
- Antibody-Directed Enzyme Prodrug Therapy
- Anti-Cancer Peptides
- Antiglycolytics and Cancer
- Anti-Her2/Neu Peptide Mimetic
- Antihormonal Therapy
- Antihormones
- Anti-inflammatory Drugs
- Antimitotic Drugs
- Antioxidant Enzymes
- Antisense DNA Therapy
- Antiviral Defenses
- Antizyme Inhibitor
- AP-1
- APAF-1 Signaling
- APC Gene in Familial Adenomatous Polyposis
- APC/β-Catenin Pathway
- Apico-Basal Polarity
- Apoptosis
- Apoptosis Induction for Cancer Therapy
- Appendiceal Epithelial Neoplasms
- Aptamer Bioconjugates for Cancer Therapy
- Arachidonic Acid Pathway
- ARF Tumor Suppressor Protein
- Arginine
- Arginine-Depleting Enzyme Arginine Deiminase
- Aromatase and Its Inhibitors
- Aromatic Amine
- Array CGH
- Arrhenoblastoma
- Arsenic
- Artemisinin
- Aryl Hydrocarbon Receptor
- Arylamine N-Acetyltransferases
- Asbestos
- Ascites
- Askin Tumor
- Aspirin
- Astrocytoma
- Asymmetric Cell Division
- ATM Protein
- Aurora Kinases
- Autoantibodies
- Autocrine Signaling
- Autoimmunity and Cancer
- Autophagy
- Autotaxin
- 5-aza-2′ Deoxycytidine
- B
- Bacillus Calmette-Guérin
- BARD1
- Barrett Esophagus
- Basal Cell Carcinoma
- Basalioma
- B-Cell Lymphoma
- B-Cell Tumors
- Bcl2
- BCL3
- BCL6 Translocations in B-Cell Tumors
- BCR-ABL1
- Beckwith-Wiedemann Syndrome
- Beckwith-Wiedemann Syndrome Associated Childhood Tumors
- Behcet Disease
- Benign Prostate Hyperplasia
- Benzene and Leukemia
- Benzpyrene
- Beta-Glucosidase
- Betulinic Acid
- Bevacizumab
- Bid
- BIK Proapoptotic Protein
- Bile Acids
- Bile Duct Neoplasms
- Bin1
- Bioavailability
- Bioconjugate
- Bioluminescence Imaging
- Biomarkers in Detection of Cancer Risk Factors and in Chemoprevention
- Biomonitoring
- Birt-Hogg-Dubé Syndrome
- Bispecific Antibodies
- Bisphosphonates
- Bladder Cancer
- Bladder Cancer Molecular Therapy
- Bladder Cancer Pathology
- Blast Crisis
- Bleomycin
- Blood-Brain Barrier
- Bloom Syndrome
- Bone Loss Cancer Mediated
- Bone Metastasis
- Bone Tropism
- Bone Tumors
- BORIS
- Bortezomib
- Bovine Papillomavirus
- Bowen Disease
- Brachytherapy
- BRaf-Signaling
- BRAF Somatic Alterations
- Brain Cancer Pathology
- Brain Tumors
- BRCA1/BRCA2 Germline Mutations and Breast Cancer Risk
- Breast Cancer
- Breast Cancer Antiestrogen Resistance
- Breast Cancer Carcinogenesis
- Breast Cancer Drug Resistance
- Breast Cancer Epidemiology
- Breast Cancer Familial Risk
- Breast Cancer Immunotherapy
- Breast Cancer Multifocality
- Breast Cancer Multistep Development
- Breast Cancer New Therapies: HER2, VEGF, and PARP as Targets
- Breast Cancer Prognostic and Predictive Biomarkers
- Breast Cancer Prognostic Biomarkers
- Breast Cancer Stem Cells
- Breast Cancer Susceptibility Genes
- BRIT1 Gene
- BRMS1
- Bryostatin-1
- Burkitt Lymphoma
- Bystander Effect
- C
- Ca2+ Homeostasis
- Cachexia
- Cafe-Au-Lait Spots
- Cajal Bodies
- Calcitonin
- Calcium-Binding Proteins
- Calpain
- Calreticulin
- CAMTA1
- Cancer
- Cancer and Cadmium
- Cancer Causes and Control
- Cancer Epidemiology
- Cancer Epigenetics
- Cancer Germline Antigens
- Cancer Stem Cells Targeted Drug Development
- Cancer Stem-Like Cells
- Cancer Vaccines
- Cannabinoids
- Carbon Metabolism
- Carbonyl Metabolism
- Carcinoembryonic Antigen
- Carcinogen Metabolism
- Carcinogenesis
- Carcinoid
- Carcinoid Tumors
- Carcinoma In Situ
- Carcinomatosis
- Carcinosarcoma
- Cardiac Tumors
- Carney Complex
- Carotenoids
- Case Control Association Study
- Caspase
- Caspase-8
- Caspase-Independent Apoptosis
- Castrate-Resistant Prostate Cancer
- Castration-Resistant Prostate Cancer
- Cathepsin-D
- Cathepsins
- Caveolins
- CBP/p300 Coactivators
- CCCTC-Binding Factor
- CD Antigens
- CD26/DPPIV in Cancer Progression and Spread
- CD44
- CDCP1
- CDKN2A
- CDX2
- CEA Gene Family
- CEACAM1 Adhesion Molecule
- Celastrol
- Celecoxib
- Cell Adhesion Molecules
- Cell Biology
- Cell Cycle Checkpoint
- Centrosome
- Ceramide
- Cervical Cancers
- Cetuximab
- Chelators as Anti-Cancer Drugs
- Chemical Carcinogenesis
- Chemically Induced Cell Transformation
- Chemoattraction
- Chemokine Receptor CXCR4
- Chemokines
- Chemoprevention
- Chemoprotectants
- Chemoradiotherapy
- Chemosensibilization
- Chemotherapy
- CHFR
- Childhood Adrenocortical Carcinoma
- Childhood Cancer
- Childhood Cancer and Pediatric Cancer Predisposition Syndromes
- Childhood Cancer and Treatment-Related Toxicities
- Chimeric Antigen Receptor (CAR)
- Chimeric Antigen Receptor on T Cells
- Chinese Versus Western Medicine
- Cholangiocarcinoma
- Choline Kinase
- Chorioallantoic Membrane
- Chromatin Remodeling
- Chromium Carcinogenesis
- Chromophore-Assisted Laser Inactivation
- Chromosomal Fluorescence In Situ Hybridization
- Chromosomal Instability
- Chromosomal Translocation t(8;21)
- Chromosomal Translocations
- Chronic Lymphocytic Leukemia
- Chronic Myeloid Leukemia
- Chronic Obstructive Pulmonary Disease and Lung Cancer
- Cip-Interacting Zinc Finger Protein 1 Ciz1
- Circadian Clock Induction
- Circulating Nucleic Acids
- Circulating Tumor Cells
- Cisplatin
- CK2
- Cladribine
- Class II Tumor Suppressor Genes
- Clinical Cancer Biomarkers
- Clinical Trial
- Clusterin
- Coagulopathy
- Coffee Consumption
- Cohesins
- Cohort Study
- Colon Cancer Carcinogenesis in Human and in Experimental Animal Models
- Colon Cancer Classification
- Colon Cancer Genomic Pathways
- Colon Cancer Molecular and Targeted Experimental Therapy
- Colon Cancer Pathology of Hereditary Forms
- Colorectal Cancer
- Colorectal Cancer Chemoprevention
- Colorectal Cancer Clinical Oncology
- Colorectal Cancer Nutritional Carcinogenesis
- Colorectal Cancer Pathology
- Colorectal Cancer Premalignant Lesions
- Colorectal Cancer Therapeutic Antibodies
- Colorectal Cancer Vaccine Therapy
- Combinatorial Cancer Therapy
- Combinatorial Selection Methods
- Comet Assay
- Comparative Oncology
- Complement-Dependent Cytotoxicity
- Confocal Laser-Scanning Microscopy In Vivo
- Conjugated Linolenic Acids
- Connexins
- Constitutive Androstane Receptor
- Contact Normalization
- Contralateral Breast Cancer
- Convection-Enhanced Delivery
- Cortactin
- Cowden Syndrome
- COX-2 in Colorectal Cancer
- CpG Islands
- Cripto-1
- Crohn Colitis
- Crohn Disease
- Cryosurgery
- Cryptotanshinone
- Crypts
- Cucurbitacin B
- Cullin Ubiquitin E3 Ligases
- Curcumin
- Cushing Syndrome
- Cutaneous Desmoplastic Melanoma
- Cyclin D
- Cyclin G-Associated Kinase
- Cyclin-Dependent Kinases
- Cyclins
- Cyclooxygenase
- Cyclophosphamide
- Cylindromatosis
- Cystatins
- Cystic Fibrosis
- Cystic Nephroma
- Cytochalasin B
- Cytochrome P450
- Cytokine
- Cytokine Receptor as the Target for Immunotherapy and Immunotoxin Therapy
- Cytoskeleton
- Cytotoxic T Cells
- D
- Dactinomycin
- Daxx
- Death Receptors
- Decatenation G2 Checkpoint
- Decay-Accelerating Factor
- Decoy Receptor
- Decoy Receptor 3
- Deferasirox
- Deleted in Malignant Brain Tumors 1
- Deleted in Pancreatic Carcinoma Locus 4
- Dendritic Cells
- Dental Pulp Neoplasms
- Desmoglein-2
- Desmoid Tumor
- Desmoplasia
- Desmoplastic Small Round Cell Tumor
- Desmosomes
- Detoxification
- Diabody
- Diethylstilbestrol
- Diffuse Large B-Cell Lymphoma
- Dimethylfumarate
- Dioxin
- DLC1
- DNA Damage
- DNA Damage Response
- DNA Damage Response Genes
- DNA Damage Tolerance
- DNA Damage-Induced Apoptosis
- DNA Oxidation Damage
- DNA Vaccination
- Docetaxel
- Dormancy
- Doublecortin
- Drug Delivery Systems for Cancer Treatment
- Drug Design
- Drug Discovery
- Drug Resistance
- Ductal Carcinoma In Situ
- Duffy Antigen Receptor for Chemokines
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Dysplasia
- E
- E T V6
- E2A-PBX1
- Early B-Cell Factors
- Early Genes of Human Papillomaviruses
- Early-Stage Ovarian Cancer
- E-Box
- E-Cadherin
- Efferocytosis
- Eicosanoids
- Electromagnetic Fields
- Electroporation
- ELISA
- Elongin BC Complex
- Embryonic Stem Cells
- Endocan
- Endocrine Oncology
- Endocrine Therapy
- Endocrine Therapy in Breast Cancer
- Endocrine-Related Cancers
- Endocytosis
- Endometrial Cancer
- Endometrioma
- Endoplasmic Reticulum Stress
- Endosomal Compartments
- Endostatin
- Endothelial-Derived Gene-1
- Endothelins
- EpCAM
- Eph Receptors
- Epidemiology of Cancer
- Epidermal Growth Factor Inhibitors
- Epidermal Growth Factor Receptor
- Epidermal Growth Factor-like Ligands
- Epigallocatechin
- Epigenetic
- Epigenetic Biomarker
- Epigenetic Gene Silencing
- Epigenetic Modifications
- Epigenetic Therapy
- Epigenomics
- Epithelial Tumorigenesis
- Epithelial-to-Mesenchymal Transition
- Epithelium
- Epothilone B Analogue
- Epothilones
- Epstein-Barr Virus
- Epstein–Barr Virus Latent Membrane Protein 1
- Erlotinib
- ERM Proteins
- Erythroleukemia
- Erythropoietin
- E-Selectin-Mediated Adhesion and Extravasation in Cancer
- Esophageal Adenocarcinoma
- Esophageal Cancer
- Estradiol
- Estrogen Receptor
- Estrogen Signaling
- Estrogenic Hormones
- Ether à-go-go Potassium Channels
- Etidronate
- Etoposide
- Ets Transcription Factors
- Everolimus
- Ewing Sarcoma
- EWS-FLI (ets) Fusion Transcripts
- Exfoliation of Cells
- Exosomal miRNA
- Exosome
- Extracellular Matrix Remodeling
- Extracellular Signal-Regulated Kinases 1 and 2
- Extrapulmonary Small Cell Cancer
- F
- Fanconi Anemia
- Farnesylation
- Fatty Acid Transport
- FDG-PET
- Fecal Immunochemical Test
- Fecal Occult Blood Test
- Fenretinide
- Ferroptosis
- Fever of Unknown Origin
- Fibrinogen
- Fibroblast Growth Factors
- Fibronectin
- Fibrosarcoma
- Fibrosis and Cancer
- Fibulins
- Fine Needle Aspiration Biopsy
- Firestorm Pattern
- Flavonoids
- FLICE-Inhibitory Protein
- Flow Cytometry
- FLT3
- Fludarabine
- Fluorescence Diagnostics
- Fluorescence in Situ Hybridization
- Fluorouracil
- Fluoxetine
- Focal Adhesion Kinase
- Follicular Lymphoma
- Follicular Thyroid Tumors
- Follistatin
- Food-Borne Carcinogens
- Forkhead Box M1
- Fragile Histidine Triad
- Fragile Sites
- Fucosylation
- α1-6 Fucosyltransferase
- Fucoxanthin
- Fulvestrant
- Fumarate Hydratase
- Funnel Factors
- Furin
- Fusion Genes
- G
- G Proteins
- G2/M Transition
- GAGE Proteins
- Gain-of-Function p53
- Gallbladder Cancer
- Gangliosides
- Gankyrin
- Gap Junctions
- Gastric Cancer
- Gastric Cancer Therapy
- Gastrin
- Gastrinoma
- Gastrin-Releasing Peptide
- Gastrointestinal Stromal Tumor
- Gefitinib
- Gelsolin
- Gemcitabine
- Gene Therapy
- Genetic Toxicology
- Genistein
- Genomic Imbalance
- Genomic Imprinting
- Genomic Instability
- Germinoma
- Giant Cell Tumor
- Ginkgo biloba
- Gleason Grading
- GLI Proteins
- Glioblastoma Therapy
- Glucose Metabolism
- Glutathione Conjugate Transporter RLIP76
- Glutathione S-Transferase
- Glycobiology and Cancer
- Glycosylation
- Gonadotropin-Releasing Hormone
- Good Laboratory Practices
- Good Manufacturing Practices
- Grading of Tumors
- Graft Acceptance and Rejection
- Granulosa Cell Tumors
- Grape Seed Extract
- Graves Disease
- Green Tea Cancer Prevention
- Growth Hormone-Releasing Hormone
- GTPase
- Gut Microbiota
- Gut Peptides
- Gynecomastia
- H
- γH2AX
- Hairy Cell Leukemia
- Hamartin
- Haploinsufficiency
- HB-EGF
- HDAC Inhibitors
- Head and Neck Cancer
- Hedgehog Signaling
- Helicobacter Pylori in the Pathogenesis of Gastric Cancer
- Hematological Malignancies, Leukemias, and Lymphomas
- Heparanase
- Heparanase Inhibitors
- Hepatic Epithelioid Hemangioendothelioma
- Hepatic Ethanol Metabolism
- Hepatitis B Virus
- Hepatitis B Virus x Antigen-Associated Hepatocellular Carcinoma
- Hepatitis C Virus
- Hepatoblastoma
- Hepatocellular Carcinoma
- Hepatocellular Carcinoma Molecular Biology
- Hepatocellular Carcinoma: Etiology, Risk Factors, and Prevention
- HER-2/neu
- Herceptin
- Herpesvirus-Associated Ubiquitin-Specific Protease De-ubiquitinase
- Heterochromatin
- Heterocyclic Amines
- Hexavalent Chromium
- Hexokinase 2
- Histocompatibility
- Histocompatibility Antigens
- Histone Acetyltransferases
- Histone Modification
- HLA Class I
- Hodgkin and Reed/Sternberg Cell
- Hodgkin Disease
- Hodgkin Lymphoma, Clinical Oncology
- Hollow Fiber Assay
- Homeobox Genes
- Homing Peptides and Vascular Zip Codes
- Homologous Recombination Repair
- Hormonal Carcinogenesis
- Hormonal Therapy
- Hormone Replacement Therapy
- Hormone-Refractory Prostate Cancer
- Hormones
- HRAS
- HSNF5/INI1/SMARCB1 Tumor Suppressor Gene
- Hsp90
- HSV-TK-/Ganciclovir-Mediated Toxicity
- Human Herpesvirus 6
- Human Papillomaviruses in Head and Neck Cancer
- Human T-Lymphotropic Virus
- Huntingtin Interacting Protein 1
- HuR
- Hurthle Cell Adenoma and Carcinoma
- Hyaluronan Synthases
- Hyaluronidase
- Hydrogen Peroxide
- 2-Hydroxyoleic Acid
- Hypericin
- Hyperplasia
- Hyperthermia
- Hypomethylation of DNA
- Hypoxia
- Hypoxia-Inducible Factor-1
- I
- IA4
- IAP-3
- IARC TP53 Database
- ICF Syndrome
- ICL670A
- Idiopathic Myelofibrosis
- Idiotype Vaccination
- Idiotypic Vaccination
- IDO
- I-FLICE
- iFOBT
- IgE-Mediated Hypersensitivity
- IHC
- IL-6
- ILP1
- Imatinib
- Imatinib (Gleevec)
- Imatinib Mesylate
- Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-
- Immediate Early Stress Response
- Immune Escape
- Immune Responses to Autoantigens
- Immune-Mediated Suppression
- Immunochemical Fecal Occult Blood Test
- Immunocytochemistry
- Immunoediting
- Immunoglobulin Rearrangements
- Immunohistochemistry
- Immunohistology
- Immunoliposomes
- Immunological Fecal Occult Blood Test
- Immunophenotypic Determinants
- Immunoprevention
- Immunoprophylaxis of Cancer
- Immunoproteasome
- Immunoreceptor
- Immunosuppression and Cancer
- Immunosurveillance of Tumors
- Immunotherapy
- Immunotoxins
- Imprinting
- In Situ Breast Cancer
- In Situ Cancer
- In Situ Carcinoma
- In Utero Exposure to Carcinogenic Agents
- In Vitro Bystander Effect
- In Vitro Genetics
- In Vivo Bystander Effect
- Indirect Effect
- Indirubin and Indirubin Derivatives
- Individualized Treatment
- Indoleamine 2,3-Dioxygenase
- Induced Pluripotent Stem Cells
- Induction Chemotherapy
- Infiltration
- Inflammation
- Inflammatory Bowel Disease (also includes Ulcerative Colitis)-Related Cancer
- Inflammatory Bowel Disease-Associated Cancer
- Inflammatory Breast Cancer
- Inflammatory Response and Immunity
- Inflammosome
- Infusion of T Cells
- INHBA
- INHBB
- INHBC
- INHBE
- Inherited Human Polycystic Kidney Disease
- Inhibin-β Chain
- Inhibitor of FLICE
- INK4A
- Innate Immunity
- Inositol Lipids
- Insulin Receptor
- Insulin Signaling
- Insulin-Like Growth Factor (IGF) Signaling
- Insulin-Like Growth Factors
- Insulinoma
- Integrated Positron Emission Tomography/Computed Tomography
- Integrin Signaling
- Integrin-Mediated Death
- Interferon-Alpha
- Interleukin-17
- Interleukin-4
- Interleukin-6
- Intermediate Endpoint
- Intermediate Junction
- Intermediately or Poorly Differentiated Lymphocytic Lymphoma
- Internalization
- Interphase Cytogenetics
- Intersectin
- Interstitial Microinfusion
- Intestinal Alkaline Phosphatase
- Intestinal Metaplasia
- Intestinal Organoids
- Intestinal Sphere
- Intracerebral Clysis
- Intracerebral Microinfusion
- Intraductal Carcinoma
- Intraductal Papillary Mucinous Tumor
- Intraocular Melanoma
- Intrinsically Disordered Proteins
- Intrinsically Unfolded Proteins
- Intrinsically Unstructured Proteins
- 3D In Vitro Culture
- Invadosome
- Invasion
- Ion Channels
- Ionizing Radiation (IR)-Induced Protein-8 (XIP-8)
- Ionizing Radiation Therapy
- Ionizing Radiation-Induced Cancer
- IPL1
- iPS Cells
- iPSCs
- IQ Motif-Containing GTPase-Activating Protein
- IQGAP1 Protein
- Irinotecan
- Iron-Regulated Necrosis
- Islet Cell Tumor
- Islet Cell Tumors
- Islet Cell Tumors (Pancreatic NET)
- Isoflavones
- (-)-1-Isothiocyanato-4(R)-(methylsulfinyl) Butane
- Ixabepilone
- J
- J1 220/200
- JAB1
- Japanese Silver Apricot
- Jasmonates in Cancer Therapy
- Jelly Belly
- JFY1
- JmjC Domain-Containing Protein 3
- JMJD3
- JNK Subfamily
- JNK1
- JNK2
- JNK3
- Jumonji Domain-Containing Protein 3
- Juvenile Type
- K
- Kallikreins
- Kaplan-Meier Survival Analysis
- Kaposi Sarcoma
- KDM6
- Kinetochore–Microtubule Interactions
- KISS1
- Kit/Stem Cell Factor Receptor in Oncogenesis
- Klatskin Tumors
- Klotho Tumor Suppressor
- Knudson Hypothesis
- Koch's Postulates
- KRAS
- KRAS in Colorectal Cancer Therapy
- KSP Mitotic Spindle Motor Protein
- Kupffer Cells
- L
- Lactoferricin Antiangiogenesis Inhibitor
- Laminin Signaling
- Langerhans Cell Histiocytosis
- Large Cell Neuroendocrine Carcinoma
- Laryngeal Carcinoma
- Latency-Associated Nuclear Antigen (LANA)
- Lats in Organ Size Regulation and Cancer
- Lead Exposure
- Lead Optimization
- Leiomyosarcoma
- Lentiviral Vectors
- Leptomeningeal Dissemination
- Leukemia Inhibitory Factor
- Leukemia Stem Cells
- Leukotrienes
- Lewis Antigens
- Leydig Cell Tumor
- Li-Fraumeni Syndrome
- LINE-1 Elements
- Linkage Disequilibrium
- Linoleic Acid
- Lipid Mediators
- Lipid Peroxidation
- Lipid Raft
- Lipocalin
- Lipoma-Preferred Partner
- Liposomal Chemotherapy
- 5-Lipoxygenase
- Live Cell Imaging
- Lobular Involution of the Breast
- Locoregional Therapy
- Log-Kill Hypothesis
- LPA
- Luciferase Reporter Gene Assays
- Lugol-Unstained Lesion
- Lunasin
- Lung Cancer
- Lung Cancer and Smoking Behavior
- Lung Cancer Clinical Oncology
- Lung Cancer Epidemiology
- Lung Cancer Pharmacogenomics
- Lung Cancer Staging
- Lung Cancer Targeted Therapy
- Lymphadenectomy
- Lymphangiogenesis
- Lymphatic Vessels
- Lynch Syndrome
- Lysophosphatidylcholine
- M
- Macrophages
- Macrophage-Stimulating Protein
- MAGE-A11
- Maintenance Chemotherapy
- Major Vault Protein
- Male Breast Cancer
- Malignancy-Associated Changes
- Malignant Lymphoma: Hallmarks and Concepts
- MALT Lymphoma
- Mammalian Target of Rapamycin
- MammaPrint Test
- Mammographic Breast Density and Cancer Risk
- Mammographic Density
- Mantle Cell Lymphoma
- MAP Kinase
- Marginal Zone B-Cell Lymphoma
- Maspin
- Mast Cells
- Mastocytosis
- Matrix Metalloproteinases
- Mcl Family
- Mcl-1
- MCT-1 Oncogene
- MDM Genes
- MDM2
- Medullary Thyroid Cancer Targeted Therapy
- Melanocytic Tumors
- Melanoma Antigens
- Melanoma Drug Treatment
- Melanoma Vaccines
- Melanoma-Associated Retinopathy
- Melatonin
- Membrane Transporters
- Membrane-Linked Docking Protein
- Membrane-Lipid Therapy
- Menopausal Symptoms After Breast Cancer Therapy
- Merlin
- Mesenchymal Stem Cells
- Mesoblastic Nephroma
- Mesothelin
- Mesothelioma
- MET
- Meta-Analysis
- Metabolic Polymorphisms and Cancer Susceptibility
- Metabolic Reprogramming
- Metal Drugs
- Metastasis
- Metastasis Suppressor Gene
- Metastasis Suppressor KAI1/CD82
- Metastatic Breast Cancer Experimental Therapeutics
- Metastatic Colonization
- Methoxyestradiol
- Methylation
- Methylation-Controlled J Protein
- Methyltransferases
- Metronomic Chemotherapy
- MIC Molecules
- MIC-1
- Microarray (cDNA) Technology
- Microcell-Mediated Chromosome Transfer
- Microcystin-LR
- Micrometastasis
- Micronucleus Assay
- MicroRNA
- Microsatellite Instability
- Microtubule-Associated Proteins
- Migration
- Mineral Nutrients
- Minimal Residual Disease
- Minodronate
- Mismatch Repair in Genetic Instability
- Mitochondrial DNA
- Mitochondrial Membrane Permeabilization in Apoptosis
- Mitogen-Activated Protein Kinase Kinase Kinases
- Mitogen-Inducible Gene 6 in Cancer
- Mitomycin C
- Mitotic Arrest-Deficient Protein 1
- Mitotic Catastrophe
- Modifier Loci
- Modular Transporters
- Molecular Chaperones
- Molecular Imaging
- Molecular Pathology
- Molecular Therapy
- Monoclonal Antibodies for Cancer Therapy
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Motility
- Mouse Models
- mRNA Translation
- Mucins
- Mucoepidermoid Cancer
- Multigene Array
- Multiple Endocrine Neoplasia Type 1
- Multiple Myeloma
- Multistep Development
- Mutagen Sensitivity
- Mutation Rate
- Mutator Phenotype
- MUTYH-Associated Colorectal Polyposis
- MYB
- MYC Oncogene
- Myeloablative Megatherapy
- Myelodysplastic Syndromes
- Myelosuppression
- Myopodin
- Myxoid Liposarcoma
- N
- N-(4-hydroxyphenyl)retinamide
- NA1/NA2
- NAALADase
- NAB
- NaCHOleate
- NAD-Dependent Deacetylase Sirtuin-1
- Naevoid Basal Cell Carcinoma Syndrome
- NAG-1
- NAME
- Nanocapsules
- Nanoformulations
- Nanomedicine
- Nanoparticles
- Nanoparticles in Cancer Therapy
- Nanoparticles in Diagnosis and Treatment
- Nanospheres
- Nanotechnology
- Nasopharyngeal Carcinoma
- NAT
- Natural Immunity
- Natural Killer Cell Activation
- Natural Killer Group 2D
- Natural Products
- Natural Yellow 3
- Naturally Disordered Proteins
- Naturally Unfolded Proteins
- Naturally Unstructured Proteins
- NBCCS
- NBK (Natural Born Killer)
- NCA-160
- NCI60_003316
- NCoA3
- ncRNA
- Necroptosis
- Necrosis
- Needle Aspiration Biopsy
- Needle Biopsy
- Nek2
- Nemosis
- Neoadjuvant Chemotherapy (Neoadjuvant Therapy)
- Neoadjuvant Therapy
- Neoplastic Meningitis
- Neovascularization
- Nephroblastoma
- Nestin
- NET
- Neuroblastoma
- Neurocytoma
- Neuroectodermal Tumor
- Neuroendocrine Carcinoma
- Neuroendocrine Neoplasms
- Neuroendocrine Tumors of the Pancreas
- Neuroepithelioma
- Neurofibromatosis 1
- Neurofibromatosis 2
- Neurokinins
- Neuromedin
- Neuronectin
- Neuron-Restrictive Silencer Factor (NRSF)
- Neuro-oncology: Primary CNS Tumors
- Neuropathy
- Neuropeptides
- Neuropilin Ligands
- Neuroprotection
- Neurotrophic Factors
- Neurotrophins
- Neutropenia
- Neutrophil Elastase
- Neutrophil Elastase 2
- Neutrophil Expressed (ELANE as the official gene symbol)
- Nevi
- Nevocellular Nevus
- Nevus
- New York Esophageal Squamous Cell Carcinoma 1
- Nexavar
- NF1
- NF2
- NF2 Gene Product
- NF-κB
- NGF Family
- NGRD2
- Nickel Carcinogenesis
- Nickel Tumorigenesis
- Nickel-Induced Cell Transformation
- Nicotine Addiction
- Nicotine Dependence
- Nijmegen Breakage Syndrome
- Nilotinib
- Nitric Oxide
- Nitrogen-Containing Bisphosphonate
- NK Cell Induction
- NK Cell Stimulation
- NKG2D
- NKG2D Receptor
- N-myc Downstream-Regulated Gene
- N-myc Downstream-Regulated Gene, NDRG1
- Nodularin
- Nonclassical Apoptosis
- Noncoding RNA
- Noninvasive breast Cancer
- Nonprimary APC Mutation Colorectal Cancer
- Non-Rhabdomyosarcoma Soft Tissue Sarcomas
- Non-Seminomatous Germ Cell Tumor
- Non-Small-Cell Lung Cancer
- Nonspecific Cross-Reacting Antigen with a Mw of 160kD
- Nonsteroidal Anti-inflammatory Drugs
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Nontargeted Effect
- Non-Targeted Effects
- Nonviral Vector for Cancer Therapy
- Norton-Simon Hypothesis
- Notch/Jagged Signaling
- NPC
- NPP2
- NR1C
- NR1I3
- NR3C4
- NRSTS
- NS3
- NSC-10514-F
- NSC-312887
- NSC362856
- NSC-638850
- NSC-684766
- NSC-710428
- Nuclear Factor-KappaB
- Nuclear Factor-κB
- Nuclear Receptor Coactivator 3
- Nuclear Receptor Subfamily 1, Group I, Member 2 (NR1I2)
- Nuclear Receptors
- Nucleic Acid-Based Biomarkers
- Nucleolin
- Nucleoporin
- Nucleosome Remodeling
- Nucleotide Excision Repair
- NUP98-HOXA9 Fusion
- NUPR1
- Nutraceuticals
- Nutrition Status
- Nutritional Factors
- Nutritional Prevention of Colon Cancer
- NY ESO 1
- NY-ESO-1
- O
- Obesity and Cancer Risk
- Okadaic Acid
- Oligoastrocytomas
- Oligodendroglioma
- Omental Immune Aggregates
- OncoArray
- Oncofetal Antigen
- Oncogene
- Oncogene Addiction
- Oncology Models in Mice
- Oncolytic Adenovirus
- Oncolytic Virus
- Oncopeptidomics
- Oncoplastic Surgery
- Oncostatin M
- Oncotype DX
- Optimal Treatment for Women with Ovarian Cancer
- Oral Cancer
- Orphan Nuclear Receptors
- Osteoblastic Bone Lesion
- Osteochondroma
- Osteoclast
- Osteolysis
- Osteopontin
- Osteoporosis
- Osteosarcoma
- Ovarian Cancer
- Ovarian Cancer Chemoresistance
- Ovarian Cancer Chemotherapy
- Ovarian Cancer Clinical Oncology
- Ovarian Cancer Drug Resistance
- Ovarian Cancer Epidemiology
- Ovarian Cancer Hormonal Therapy
- Ovarian Cancer Immunotherapy
- Ovarian Cancer Pathology
- Ovarian Cancer Stem Cells
- Ovarian Germ Cell Tumors
- Ovarian Mucinous Carcinoma
- Ovarian Serous Carcinoma
- Ovarian Small Cell Carcinoma Hypercalcemic Type
- Ovarian Stromal and Germ Cell Tumors
- Ovarian Tumors During Childhood and Adolescence
- Oxidative Stress
- Oxygen Sensing
- Oxygenation of Tumors
- P
- p21
- p27
- p53 Family
- P8 Protein
- Paclitaxel
- Palladium-Based Anti-Cancer Therapeutics
- Palliative Therapy
- Pancreatic Cancer
- Pancreatic Cancer Basic and Clinical Parameters
- Pancreatic Cancer Biology and Management
- Pancreatic Cancer Biomarkers
- Pancreatic Cancer Desmoplastic Reaction and Metastasis
- Pancreatic Cancer Development and Regeneration
- Pancreatic Cancer Metastasis
- Pancreatic Cancer Pathogenesis
- Pancreatic Cancer Stem Cells
- Pancreatic Cancer Molecular Targets for Therapy
- Pancreatitis
- Pannexins
- Papanicolaou Test
- Papillary Thyroid Carcinoma
- PARAHOX
- Parathyroid Hormone-Related Protein
- PARP Inhibitors
- Particle-Induced Cancer
- Pathology
- Paxillin
- PCA3
- PDT-Induced Apoptosis
- Pediatric Brain Tumors
- Pediatric HIV/AIDS
- Pemetrexed
- Pentakisphosphate
- Peptide Biomarkers
- Peptide Vaccines for Cancer
- Peptidylarginine Deiminase Enzymes
- Periostin
- Peripheral Neuropathy
- Peroxisome Proliferator-Activated Receptor
- Personalized Cancer Medicine
- Peutz–Jeghers Syndrome
- P-Glycoprotein
- Phage Display
- Pharmacogenomics in Multidrug Resistance
- Pharmacokinetics and Pharmacodynamics in Drug Development
- Pharmacophore
- Phase II Enzymes
- Pheochromocytoma
- Phosphatase
- Phospholipase A2
- Phospholipase D
- Photocarcinogenesis
- Photochemoprevention
- Photodynamic Therapy
- Photo-Induced DNA Damage
- Photothermal Therapy
- Phytochemicals in Cancer Prevention
- Phytoestrogens
- PI3K Signaling
- PICALM
- PIK3CA
- PIM Protein Kinase Family
- Placenta Growth Factor
- Placental Site Trophoblastic Tumor
- Plasmacytoma
- Plasminogen-Activating System
- Platelet
- Platelet-Activating-Factor
- Platelet-Derived Growth Factor
- Platinum Complexes
- Platinum-Refractory Testicular Germ Cell Tumors
- Pleiotrophin
- Pleural Effusion
- Plexins
- Podoplanin
- POEMS Syndrome
- Poly(ADP-Ribosyl)ation
- Polyamines
- Polycomb Group
- Polycyclic Aromatic Hydrocarbons
- Polycystic Kidney Disease
- Polycythemia
- Polyphenols
- Polyunsaturated Fatty Acids
- Positron Emission Tomography
- Preclinical Testing
- Pre-mRNA Splicing
- Preneoplastic Lesions
- Presenilin
- Primary Myelofibrosis
- Probiotics and Cancer
- Progestin
- Programmed Cell Death 4
- Progression
- Prolactin
- Prostaglandins
- Prostate Cancer
- Prostate Cancer Chemotherapy
- Prostate Cancer Clinical Oncology
- Prostate Cancer Diagnosis
- Prostate Cancer Epidemiology
- Prostate Cancer Experimental Therapeutics
- Prostate Cancer Genetic Toxicology
- Prostate Cancer Hormonal Therapy
- Prostate Cancer Molecularly Targeted Therapies
- Prostate Cancer Prevention
- Prostate Cancer Radionuclide Imaging
- Prostate Cancer Radionuclide Therapy
- Prostate Cancer Stem Cells
- Prostate Cancer Targeted Therapy
- Prostate-Specific Antigen
- Prostate-Specific Membrane Antigen
- Protease-Activated Receptor Family
- Protease-Activated Receptors
- Proteasome
- Proteasome Inhibitors
- Protein Kinase C Family
- Protein Kinases
- Proteinase-Activated Receptor-1
- Proteinase-Activated Receptor-2
- Proteinase-Activated Receptor-3
- Proteinase-Activated Receptor-4
- Proteinchip
- 14-3-3 Proteins
- Proteomics
- Proton Beam Therapy
- Prune
- Pseudomyxoma Peritonei
- PUMA
- Pyroptosis
- Q
- Quantitative Structure Activity Relationship
- R
- Radiation Carcinogenesis
- Radiation Oncology
- Radiation Sensitivity
- Radiation-Induced Sarcomas After Radiotherapy
- Radioimmunotherapy
- Radiological Response Criteria
- Radioprotectors
- Radiosensitization
- Radiosensitizer
- Radon
- Raf Kinase
- RANK–RANKL Signaling
- Rap1 and Sipa-1
- Rapamycin
- RAS Activation
- RAS-Association Domain Family 1
- RAS Genes
- RAS Transformation Targets
- RE1-Silencing Transcription Factor
- Reactive Oxygen Species
- Receptor Cross-Talk
- Receptor Tyrosine Kinase Inhibitors
- Receptor Tyrosine Kinases
- Receptors
- RECK Glycoprotein
- Recombinant Therapeutics
- Rectal Cancer
- Reductases
- Regeneration
- Regorafenib
- Regulatory T Cells
- Rel
- Relaxin
- Renal Cancer Clinical Oncology
- Renal Cancer Diagnosis
- Renal Cancer Genetic Syndromes
- Renal Cancer Molecular Therapy
- Renal Cancer Pathogenesis
- Renal Cancer Targeted Therapies with Tyrosine Kinase Inhibitors
- Renal Cancer Therapy
- Renal Cancer Treatment
- Renal Cancer Trends in Molecularly Targeted Therapies
- Repair of DNA
- Replication Factories and Replication Foci
- Resistin
- Restriction Landmark Genomic Scanning
- Resveratrol
- RET
- Retinoblastoma
- Retinoblastoma Protein, Biological and Clinical Functions
- Retinoblastoma Protein, Cellular Biochemistry
- Retinoic Acid
- Retinoid Receptor Cross-Talk
- Retinoids
- Retroviral Insertional Mutagenesis
- Rhabdoid Tumor
- Rhabdomyosarcoma
- Rho Family Proteins
- Ribosome-Inactivating Proteins
- Rituximab
- RNA Interference
- RNA Polymerase I Transcription
- Ron Receptor
- Runx1
- S
- S(1–5), T16, EFEMP1, FBLN-3
- S-100 Proteins
- SAAB
- SAC
- SAHA
- Salicylate
- Salisburia adiantifolia
- Salisburia macrophylla
- Salivary agglutinin (SAG, Human)
- Salivary Gland Malignancies
- Salt Intake
- Salting
- SAPKα
- SAPKβ
- SAPKγ
- Saporin
- Scaffold Proteins
- Scatter Factor
- SCF Receptor
- SCF-R
- SCGE
- SCH52365
- Schwannoma-Derived Growth Factor
- Schwannomin
- Scirrhous
- Sclerosing Angiogenic Tumor
- Sclerosing Endothelial Tumor
- Sclerosing Epithelioid Angiosarcoma
- Sclerosing Interstitial Vascular Sarcoma
- Sclerosing Stromal Cell Tumor
- SDF-1α
- SDGF
- Sdi1
- Second Malignant Neoplasm SMN
- Second Primary Cancer SPC
- Second Primary Cancers
- Second Primary Malignancy SPM
- Second Primary Tumors
- Secondary Metabolites
- Secondary Tumor
- Secretagogues
- γ-Secretase
- Secreted Phosphoprotein 1
- Secreted Protein Acidic and Rich in Cysteine
- Securin
- “Seed and Soil” Theory of Metastasis
- SEL-12
- Selective Effect
- Selective Serotonin Reuptake Inhibitors
- Selenium
- SELEX
- SEMA
- Semanová II Syndrome
- Semaphorin
- Semaphorin Receptors
- Semaxanib (SU5416)
- Seminoma
- Seminomatous Germ Cell Tumor
- Senescence and Immortalization
- Senescence-Associated Chronic Inflammation
- Senile Involution
- Sentinel Lymph Node
- Sentinel Node
- SEREX
- Serine Elastase
- Serine Protease Inhibitor-Like Domain
- Serine Proteases (Type II) Spanning the Plasma Membrane
- Serine-Threonine Kinase Receptor-Associated Protein
- Sertoli-Leydig Cell Tumor
- Serum Biomarkers
- Seven in Absentia Homologue
- Severe Hypoxia
- Sex Cord-Stromal Tumors – Granulosa Cell Tumors
- Sex Cord-Stromal Tumors with Annular Tubules
- Sezary Syndrome
- SH2/SH3 Domains
- SH2/Src Homology 3
- SH3 Domains
- SH3p17
- SH3p18
- SH3P9
- Shark Cartilage
- Shedding of Cells
- Short Hairpin RNA
- shRNA
- SIAH
- Sicca Complex
- Sicca Syndrome
- Side Population Cells
- Signal Transducer and Activator of Transcription
- Signal Transducer and Activator of Transcription 3
- Signal Transducers and Activators of Transcription in Oncogenesis
- Signal Transduction
- Signal Transduction Inhibitor-571
- Silent Mating Type Information Regulation 2 Homolog 1
- SIMA135 (Subtractive Immunization M(+)HEp3 Associated 135 kDa Protein)
- Simian Virus 40
- Single-Cell Gel Electrophoresis Assay
- Single-Cell Microgel Electrophoresis Assay
- Single-Chain Fv Dimer
- SIR2L1
- SiRNA
- siRNA
- Sirolimus
- SIRT1
- Sirtuin 1
- Site-Specific Drug Delivery
- Sivelestat
- Sjögren Syndrome
- Skeletal Complications (Skeletal-Related Events)
- Skeletal Metastasis
- Skeletal Secondary Tumors
- Skeletrophin
- SKI390
- Skin Cancer
- Skin Carcinogenesis
- Skinny Needle
- Skipper-Schabel Model
- Skipper-Schabel-Wilcox Model
- Skp2
- SL-1
- Slit
- Sloughing of Cells
- SM-5887
- SMA- and MAD-Related Protein 4
- Smad Proteins in TGF-Beta Signaling
- SMAD4
- Small Cell and Large Cell Neuroendocrine Carcinomas (NEC) at the Highly Aggressive Pole of the Spectrum of NENs
- Small Cell Lung Cancer
- Small Cell Neuroendocrine Carcinoma
- Small Cleaved Cell Lymphoma
- Small GTP-Binding Proteins
- Small Interfering RNA
- Small Molecule Drugs
- Small Molecule Screens
- Small Round Cell Tumor
- SMARCB1
- SMAX1
- SMR
- Snail Transcription Factors
- SOCS
- Sodium Chloride
- Soft Tissue Sarcoma
- Solar Light-Induced Cancer
- Soluble ATP-Dependent Non-Lysosomal Proteolytic System
- Soluble Mesothelin-Related Proteins
- Somatic Recombination of V, D, and J Segments
- Somatic Stem Cells
- Somatocrinin
- Somatoliberin
- Somites
- Sonochemotherapy
- Sonodynamic Therapy
- Sorafenib
- Sorafenib (Nexavar)
- Sorafenib [INN]
- Sorafenibum
- Soy Phytoestrogen
- SPARC
- Spasmolytic Polypeptide SP/TFF2
- SPB
- SPC1
- Specific Immunotherapy for Melanoma
- Spectral Karyotyping
- Sphacelus
- S-Phase Damage-Sensing Checkpoints
- S-Phase-Kinase-Associated Protein 2
- Sphingolipid Metabolism
- Spinal and Bulber Muscular Atrophy (SBMA)
- Spindle Assembly Checkpoint
- Spindle Pole Body
- Spinesin (TMPRSS5)
- Spleen Tyrosine Kinase
- Sprouty
- Spry
- Squamous Cell Carcinoma
- Src
- Src Homology 2
- SRC-1: NCOA1
- SRC-2: NCOA2
- SRC-3
- SRC-3: NCOA3
- Src8
- SSRIs
- Stage IA–C Ovarian Cancer
- Staging of Tumors
- STARD12
- START Domain-Containing Protein
- STAT
- STAT3
- Staurosporine
- Steel Ligand Receptor
- Stefins
- Stem Cell Factor
- Stem Cell Imaging
- Stem Cell Markers
- Stem Cell Mobilization
- Stem Cell Plasticity
- Stem Cell Telomeres
- Stem-Like Cancer Cells
- Steroid Receptor Coactivator-3
- Steroid Receptor Coactivators
- Steroid Receptor Coactivators (SRCs): Nuclear Receptor Coactivators (NCOAs)
- Steroid Sulfatase
- Steroid Sulfohydrolase
- Steroid Tumor
- Steroid X Receptor (SXR)
- Steryl Sulfohydrolase
- STI571
- STI-571
- Sticker Sarcoma
- Stivarga
- STK12
- STK13
- STK15
- STK5
- STK6
- STK7
- STMY1
- Stomach Cancer
- STR1
- STRAP
- Stress
- Stress Response
- Stress-Activated Protein Kinase
- Stress-Induced Bystander Effect
- Stroma
- Stromagenesis
- Stromal Cell Response
- Stromal Progression
- Stromatogenesis
- Stromelysin-1
- Structural Biology
- Structural Vascular Stabilization
- STS
- Subarachnoidal Spread
- Subependymal Giant Cell Astrocytoma
- Suberoylanilide Hydroxamic Acid
- Substrate Channeling
- Subtype AML-M7
- Suicide Gene Therapy
- Sulfated Glycoprotein-2 (SGP-2)
- Sulfokinases
- Sulforaphane
- Sulfotransferases
- Sunitinib (Sutent)
- Sunlight-Induced Cancer
- Supervised Classification
- Supervised Learning
- Supportive Care
- Suppressive T Cells
- Suppressor of Invasion, Metastasis, and Angiogenesis
- Suppressors of Cytokine Signaling
- Surface Molecules
- Surface Plasmon Resonance
- Surgical Pathology
- Surgical Trauma and Cancer Recurrence
- Surrogate Endpoint
- Surrogate Endpoint Biomarker
- Surrogate Outcome
- Survivin
- Susceptibility Loci
- SV40
- SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin Subfamily b, Member 1
- Syk
- Syk Tyrosine Kinase
- SYLD (syld709613 Protein)
- Synovial Sarcoma
- Synthetic Cannabinoids
- Synuclein
- Systemic Antibody-Directed Radionuclide Therapy
- Systemic Spread of Cancer
- Systemic Therapy
- T
- T-Cell Response
- Tachykinins
- Tamoxifen
- Tankyrases
- Targeted Drug Delivery
- Targeting Cancer Stem Cells
- TAT Protein of HIV
- Taxol
- Taxotere
- TCL1
- Technical Knockout
- Telomerase
- Temozolomide
- Temsirolimus
- Tenascin-C
- Tensional Homeostasis
- Testicular Cancer
- Testicular Germ Cell Tumors
- Theranostics
- Thiazolidin
- Thioredoxin System
- Three-Dimensional Culture
- Three-Dimensional Tissue Cultures
- Thrombospondin
- Thymidine Phosphorylase
- Thymoma
- Thyroid Cancer Treatment
- Thyroid Carcinogenesis
- Tiam1
- Tight Junction
- Time of Flight
- Time-Resolved Fluorescence Resonance Energy Transfer Technology in Drug Discovery
- Tissue Inhibitors of Metalloproteinases
- Tissue Stem Cells
- TLR4
- TMPRSS2/ERG Fusions
- TNF-Related Apoptosis-Inducing Ligand
- TNF-α in HIV Infection
- Tobacco Carcinogenesis
- Tobacco-Related Cancers
- Toll-Like Receptors
- Tongue Cancer
- Topoisomerases
- Toxicogenomics
- Toxicological Carcinogenesis
- TP53
- Trabectedin
- TRAIL Receptor Antibodies
- Transcoelomic Metastasis
- Transduction of Oncogenes
- Transforming Growth Factor-Beta
- Transgenic Mouse
- Transglutaminase-2
- Transitional Cell Carcinoma
- Translesion DNA Polymerases
- Transplacental Carcinogenesis
- Trastuzumab
- Trefoil Factors
- Triple-Negative Breast Cancer
- Trophectoderm
- Tuberous Sclerosis Complex
- Tumor Antigens
- Tumor Cell-Induced Platelet Aggregation
- Tumor Microenvironment
- Tumor Necrosis Factor
- Tumor Suppression
- Tumor Suppressor Genes
- Tumor-Associated Macrophages
- Tumor–Endothelial Cross-Talk
- Tunicamycin
- Turcot Syndrome
- Tyrosine Kinase Inhibitors
- U
- Ubiquitin Ligase SCF-Skp2
- Ubiquitination
- UCN-01 Anticancer Drug
- Ultrasound Microimaging
- Uncertain or Unknown Histogenesis Tumors
- Unfolded Protein Response and Cancer
- Uranium Miners
- Urokinase-Type Plasminogen Activator
- Urothelial Carcinoma
- Urothelial Carcinoma, Clinical Oncology
- Uterine Leiomyoma
- Uterine Leiomyoma, Clinical Oncology
- UTX
- UV Radiation
- Uveal Melanoma
- V
- V(D)J Recombination
- Valproic Acid
- Vanadium
- Vascular Disrupting Agents
- Vascular Endothelial Growth Factor
- Vascular Stabilization
- Vascular Targeting Agents
- Vasculogenic Mimicry
- Vasopressin
- Villi
- Viral Oncology Epigenetics
- Viral Vector-Mediated Gene Transfer
- Virology
- Virotherapy
- Vitamin D
- Von Hippel-Lindau Disease
- Von Hippel-Lindau Tumor Suppressor Gene
- Vorinostat
- W
- Warburg Effect
- Wilms’ Tumor
- WIPI
- Withaferin A
- Wnt Signaling
- WWOX
- X
- Xenobiotics
- Xeroderma Pigmentosum
- XIAP
- Xiphophorus
- Z
- Z-Factor
- Zoledronic Acid
- Zonula Occludens Protein-1